Evidence map›Paper›PMID 40999268›Full record

ArticleWorld journal of microbiology & biotechnology2025

Immunomodulatory effect of Qihuang Biwen decoction and its postbiotic product.

Junxiang Li, Mingqian Wang, KangKang Liu, Yibo Liang, Haijuan Wang, Yang Lin, Zeqi Huo, Zhiming Zhang, Chunjiang Zhang

Abstract read
PubMed Publisher
In one paragraph

Article in World journal of microbiology & biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Antioxidants (Basel, Switzerland) · 2026
    Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Junxiang Li *School of Life Sciences, Lanzhou University, 730000, Lanzhou, China.
Mingqian Wang *School of Pharmacy, Gansu University of Chinese Medicine, 730000, Lanzhou, China.
KangKang LiuSchool of Pharmacy, Gansu University of Chinese Medicine, 730000, Lanzhou, China.
Yibo LiangGansu Institute for Drug Control, 730000, Lanzhou, China.
Haijuan WangSchool of Pharmacy, Gansu University of Chinese Medicine, 730000, Lanzhou, China.
Yang LinSchool of Life Sciences, Lanzhou University, 730000, Lanzhou, China.
Zeqi HuoSchool of Life Sciences, Lanzhou University, 730000, Lanzhou, China.
Zhiming ZhangGansu Provincial Hospital of Traditional Chinese Medicine, 730000, Lanzhou, China. zhangzhimingys@163.com.
Chunjiang ZhangSchool of Life Sciences, Lanzhou University, 730000, Lanzhou, China. chjzh@lzu.edu.cn.

Funding

Guangzhou Science and Technology Planning Project 202206010165Science and Technology Major Project of Gansu Province 22ZD1FA001Science and Technology Major Project of Gansu Province 24ZDNA003Science and Technology Major Project of Gansu Province-Enterprise Innovation Consortium Project 23ZDFA013-3
6 · The paper itself

Abstract

Microbial fermentation is a promising strategy to enhance the efficacy and functional properties of herbs. A traditional Chinese medicine formula, known as the Qihuang Biwen decoction (QHBW), has been shown to have immunomodulatory benefits in clinical and experimental studies. Nevertheless, few studies have investigated the effects of microbial-fermented QHBW (FQHBW) on immunity. In this study, we used one-way and Plackett-Burman analyses to establish the preparation process of FQHBW (crucial parameters: ratio of bacterial strains LZU-J-TSL6 and LZU-S-ZCJ was 3:1, inoculum quantity was 3%, temperature was 37℃, time was 37 h). The study found that FQHBW has increased total polysaccharide, total acid, and antioxidant capacities. The increased constituents after fermentation potentially contribute to improving the ability of FQHBW to regulate immunity. Next, its immunostimulatory activity was evaluated in cyclophosphamide (CTX)-treated mice, and the possible mechanism was studied by microbiome-metabolome analysis. As expected, FQHBW effectively ameliorated CTX-induced immunosuppression by improving organ index, lymphocyte proliferation, phagocytic function, cytokine secretion, and antioxidant profile. It protected against CTX-induced intestinal dysbiosis by promoting the abundance of Oscillospira, Allobaculum, and Coprococcus, while moderately increasing Akkermansia and reducing Staphylococcus and Streptococcus. FQHBW primarily influenced amino acid and nucleotide metabolism to benefit immunity. Unlike QHBW, FQHBW uniquely up-regulates dopamine synapses, tryptophan metabolism, and nicotinate and nicotinamide metabolism, promoting host anti-oxidation, immune system remodeling, and disease resistance. This study suggests that microbial fermentation is indeed an effective strategy to alter the properties and function of QHBW. FQHBW has the potential to replace QHBW as a novel immunoenhancer and intestinal microecological regulator.

Indexed as

Drugs, Chinese HerbalImmunologic FactorsImmunomodulating AgentsAnimalsAntioxidantsBacteriaCytokinesDysbiosisFermentationGastrointestinal MicrobiomeMaleMedicine, Chinese TraditionalMiceAntioxidantsCytokinesDrugs, Chinese HerbalImmunologic FactorsImmunomodulating AgentsGut microbiotaImmunityMetabolismMicrobial fermentation technologyQihuang Biwen Decoction

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.